/ EN
2026-08-03 00:00 United Kingdom Industry News Regulatory Approval Translated from EN

BrainPatch Wins FCC Certification for US Market

Summary BrainPatch, which makes non-invasive neurotechnology, says it has secured FCC certification, a step the company needed before it could sell its products in the US. In a blog update dated August 3, 2026, the firm said the approval confirms its technology meets US regulatory requirements and marks a milestone in its international expansion; it also brings the technology closer to buyers, partners and backers in the country it calls the largest consumer market.
Why it matters FCC certification is an early compliance gate for electronics sold in the US, so a first-party confirmation from a non-invasive neurotech firm marks a concrete step toward a consumer-market launch. For readers tracking how neurotech companies navigate US market entry, this is a verifiable signal of commercialization progress.

BCIwiki (bciwiki.com) — BrainPatch has announced it completed FCC certification, clearing the way for its non-invasive neurotechnology to be commercially distributed in the United States. The company posted the announcement on its official blog on August 3, 2026, describing the certification as confirmation that its technology meets US regulatory requirements and calling it a major milestone in its international expansion.

According to the company, the certification brings it closer to delivering its non-invasive neurotechnology to customers, partners and investors in the United States, which it calls the world's largest consumer market. "The next chapter begins," the blog post concludes.

Compiled by BCIwiki from public sources

Sources · 1
brainpatch.ai 2026-08-03
Read original ↗
Suggest a correction Revisions · none / EN
© 2026 BCIwiki.com Digest Topics Tips Subscribe Revisions About